Ipsen S.A. (EPA:IPN)
France · Delayed Price · Currency is EUR 164.50
-1.90 (-1.14%)
May 11, 2026, 5:35 PM CET
Ipsen Revenue
In the year 2025, Ipsen had annual revenue of 3.93B EUR with 9.92% growth. Ipsen had revenue of 1.99B in the half year ending December 31, 2025.
Revenue
3.93B
Revenue Growth
+9.92%
P/S Ratio
3.48
Revenue / Employee
709.88K
Employees
5,535
Market Cap
13.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.93B | 354.70M | 9.92% |
| Dec 31, 2024 | 3.57B | 268.10M | 8.11% |
| Dec 31, 2023 | 3.31B | 150.00M | 4.75% |
| Dec 31, 2022 | 3.16B | 407.80M | 14.84% |
| Dec 31, 2021 | 2.75B | 62.40M | 2.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 28.49B |
| Eurofins Scientific SE | 7.30B |
| emeis Société anonyme | 5.90B |
| Ramsay Générale de Santé | 5.36B |
| Clariane SE | 5.31B |
| bioMérieux | 4.07B |
| Sartorius Stedim Biotech | 2.98B |
Ipsen News
- 18 days ago - Ipsen Earnings Call Transcript: Q1 2026 - Transcripts
- 19 days ago - Ipsen: European Commission Grants Conditional Marketing Authorization For Ojemda - Nasdaq
- 2 months ago - Ipsen S.A. publishes its 2025 Consolidated Financial Statements - GlobeNewsWire
- 3 months ago - Ipsen Earnings Call Transcript: H2 2025 - Transcripts
- 7 months ago - Ipsen Earnings Call Transcript: Q3 2025 - Transcripts
- 10 months ago - Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) - GlobeNewsWire
- 10 months ago - Ipsen Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - Ipsen S.A. - Initiation of the share buy-back program - GlobeNewsWire